168 related articles for article (PubMed ID: 10756552)
1. [Changes in metered dose inhaler propellants].
Chinet T
Rev Mal Respir; 2000 Feb; 17(1):15-20. PubMed ID: 10756552
[TBL] [Abstract][Full Text] [Related]
2. The CFC to HFA transition and its impact on pulmonary drug development.
Leach CL
Respir Care; 2005 Sep; 50(9):1201-8. PubMed ID: 16122403
[TBL] [Abstract][Full Text] [Related]
3. Pharmaceutical transition to non-CFC pressurized metered dose inhalers.
Cripps A; Riebe M; Schulze M; Woodhouse R
Respir Med; 2000 Jun; 94 Suppl B():S3-9. PubMed ID: 10919679
[TBL] [Abstract][Full Text] [Related]
4. Switching to CFC-free beclometasone for asthma.
Drug Ther Bull; 2008 Jun; 46(6):46-8. PubMed ID: 18525059
[TBL] [Abstract][Full Text] [Related]
5. A randomized, double-blind, double-dummy, single-dose, efficacy crossover trial comparing formoterol-HFA (pMDI) versus formoterol-DPI (Aerolizer) and placebo (pMDI or Aerolizer) in asthmatic patients.
Bousquet J; Huchon G; Leclerc V; Vicaut E; Lefrançois G
Respiration; 2005; 72 Suppl 1():6-12. PubMed ID: 15915007
[TBL] [Abstract][Full Text] [Related]
6. Safety of long-term treatment with HFA albuterol.
Ramsdell JW; Klinger NM; Ekholm BP; Colice GL
Chest; 1999 Apr; 115(4):945-51. PubMed ID: 10208190
[TBL] [Abstract][Full Text] [Related]
7. Budesonide administered using chlorofluorocarbon and hydrofluoroalkane pressurized metered-dose inhalers: pharmacokinetics, pharmacodynamics and clinical equivalence.
Singh D; Tutuncu A; Lohr I; Carlholm M; Polanowski T
Int J Clin Pharmacol Ther; 2007 Sep; 45(9):485-95. PubMed ID: 17907591
[TBL] [Abstract][Full Text] [Related]
8. Effects of mometasone furoate dry powder inhaler and beclomethasone dipropionate hydrofluoroalkane and chlorofluorocarbon on the hypothalamic-pituitary-adrenal axis in asthmatic subjects.
Chrousos GP; Ghaly L; Shedden A; Iezzoni DG; Harris AG
Chest; 2005 Jul; 128(1):70-7. PubMed ID: 16002918
[TBL] [Abstract][Full Text] [Related]
9. New delivery systems and propellants.
Dolovich M
Can Respir J; 1999; 6(3):290-5. PubMed ID: 10393290
[TBL] [Abstract][Full Text] [Related]
10. Optimizing drug delivery to the lung: design of a CFC-free corticosteroid metered-dose aerosol system.
Donnell D
Drug Dev Ind Pharm; 2001 Feb; 27(2):111-8. PubMed ID: 11266222
[TBL] [Abstract][Full Text] [Related]
11. The technical transition to CFC-free inhalers.
Tansey I
Br J Clin Pract Suppl; 1997 May; 89():22-7. PubMed ID: 9519509
[TBL] [Abstract][Full Text] [Related]
12. Switching patients with asthma from chlorofluorocarbon (CFC) albuterol to hydrofluoroalkane-134a (HFA) albuterol.
Bronsky E; Ekholm BP; Klinger NM; Colice GL
J Asthma; 1999; 36(1):107-14. PubMed ID: 10077140
[TBL] [Abstract][Full Text] [Related]
13. Switch to non-CFC inhaled corticosteroids: a comparative efficacy study of HFA-BDP and CFC-BDP metered-dose inhalers.
Demedts M; Cohen R; Hawkinson R
Int J Clin Pract; 1999; 53(5):331-8. PubMed ID: 10695095
[TBL] [Abstract][Full Text] [Related]
14. Equivalence of hydrofluoroalkane (HFA) and chlorofluorocarbons (CFC) formulations of inhaled beclomethasone.
Lipworth BJ; Jackson CM
Respir Med; 2000 Feb; 94(2):177; author reply 179-80. PubMed ID: 10714427
[No Abstract] [Full Text] [Related]
15. Advances in asthma and COPD management: delivering CFC-free inhaled therapy using Modulite technology.
Acerbi D; Brambilla G; Kottakis I
Pulm Pharmacol Ther; 2007; 20(3):290-303. PubMed ID: 16890465
[TBL] [Abstract][Full Text] [Related]
16. A randomized, double-blind, double-dummy, single-dose, crossover trial evaluating the efficacy and safety profiles of two dose levels (12 and 24 microg) of formoterol-HFA (pMDI) vs. those of a dose level (24 microg) of formoterol-DPI (Foradil/Aerolizer) and of placebo (pMDI or Aerolizer) in moderate to severe asthmatic patients.
Bousquet J; Guenolé E; Duvauchelle T; Vicaut E; Lefrançois G
Respiration; 2005; 72 Suppl 1():13-9. PubMed ID: 15915008
[TBL] [Abstract][Full Text] [Related]
17. Plume temperature emitted from metered dose inhalers.
Brambilla G; Church T; Lewis D; Meakin B
Int J Pharm; 2011 Feb; 405(1-2):9-15. PubMed ID: 21129465
[TBL] [Abstract][Full Text] [Related]
18. Metered-dose inhaler formulations with beclomethasone-17,21-dipropionate using the ozone friendly propellant R 134a.
Steckel H; Müller BW
Eur J Pharm Biopharm; 1998 Jul; 46(1):77-83. PubMed ID: 9700025
[TBL] [Abstract][Full Text] [Related]
19. Cumulative dose response study comparing HFA-134a albuterol sulfate and conventional CFC albuterol in patients with asthma.
Ramsdell JW; Colice GL; Ekholm BP; Klinger NM
Ann Allergy Asthma Immunol; 1998 Dec; 81(6):593-9. PubMed ID: 9892032
[TBL] [Abstract][Full Text] [Related]
20. Equivalence of asthma control with new CFC-free formulation HFA-134a beclomethasone dipropionate and CFC-beclomethasone dipropionate.
Dahl R; Ringdal N; Ward SM; Stampone P; Donnell D
Br J Clin Pract; 1997; 51(1):11-5. PubMed ID: 9158265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
